“So, we need to increase efficiency on the process development side. While automation is one way of doing that, a much more efficient solution is to use in silico process development data to increase ...

The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...

Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process more efficient.

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

A Lloyd's of London company partnered with GATC Health to fund and insure prospective drug trials that pass the test of a new ...

"And we're not used to having somebody without a career at stake in the room at a senior level," said Hudson.

Neurocrine Biosciences Inc. has appointed Andrew Ratz, Ph.D. as Senior Vice President of Drug Development, Delivery and ...

The IRA’s price controls discourage post-marketing research. The potential benefits from expanding access to the drug to ...

Konstanz biologist Patrick Müller receives a Proof of Concept Grant from the European Research Council for his project "EmbryoNet-AI". Its goal is the further development of an AI-supported platform ...

As the pharmaceutical industry adapts to new therapies and ... phase-appropriate quality system is one of the greatest hurdles in the drug development process. AI and machine learning are transforming ...

Pharmaceutical sciences encompass a wide range of disciplines that focus on the discovery, development, and regulation of drugs ... the overall quality of the process. We however cannot guarantee ...